sales@businessmarketinsights.com +1 646 791 7070 | +91-020 69018608

Pharmacogenomics Market Size & Forecast

Historic: 2022-2024 Base Year: 2025 Forecast: 2026–2033
US$ 11.89 Billion
Market Size 2025 · Base Year
US$ 33.12 Billion
Projected Market Size by 2033
13.6%
CAGR · 2026–2033
SHARE
BMIPUB00036496 56+ Countries Covered 10 Major Companies Profiled PEST & SWOT Analysis Competitive Heat Map
At a Glance

Report Coverage

56 +
Countries
56+ countries across North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa
12
Year Assessment
Comprehensive Market Analysis Covering 3 Years of Historical Data (2022–2024), Base Year (2025), and 8-Year Forecast (2026–2033)
10 +
Major Players
Major companies profiled including Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Illumina, Inc., QIAGEN N.V., Agilent Technologies, Inc.
350
Report Pages
Pages of deep-dive analysis with PEST, SWOT, competitive heat maps and datasets
What's Fueling Growth

Market Drivers

  • AI-Driven Genomic Analysis

  • Companion Diagnostic Development Growth

  • Expansion of Next-Generation Sequencing

Where Growth Opportunities Exist

Key Opportunities

  • Personalized Drug Development Expansion

  • Growing Healthcare Digitalization Initiatives

  • Emerging Market Penetration Opportunities

What Could Slow It Down

Market Restraints

  • High Genomic Testing Costs

  • Limited Clinical Awareness Levels

  • Data Privacy Regulatory Concerns

Market Segmentation

Coverage by Segment

Type

Products
Services

Techniques

Next Generation Sequencing
Polymerase Chain Reaction
Microarrays

Application

Personalized Medicine
Drug Discovery
Others

Disease

Oncology
Neurology
Cardiology
Geographic Breakdown

Regional Intelligence

NA North America
EU Europe
APAC Asia-Pacific
SCA South & Central America
MEA Middle East & Africa
Competitive Landscape

Major Market Players

Listed for reference — companies are not ranked in any particular order.

Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
QIAGEN N.V.
Agilent Technologies, Inc.
Danaher Corporation
Bio-Rad Laboratories, Inc.
Abbott Laboratories
Myriad Genetics, Inc.
Laboratory Corporation of America Holdings (Labcorp)
What's Inside

Report Scope & Deliverables

Market Size 2025 US$ 11.89 Billion
Market Size 2033 US$ 33.12 Billion
CAGR 2026–2033 13.6%
Segments By Type (Products, Services)  |  By Techniques (Next Generation Sequencing, Polymerase Chain Reaction, Microarrays)  |  By Application (Personalized Medicine, Drug Discovery, Others)
Geographies North America (US, Canada, Mexico)  ·  Europe (Germany, Italy, France, U.K., Spain, Belgium, Netherlands, Luxembourg, Norway, Finland, Denmark, Sweden, Switzerland, Austria, Greece, Portugal, Russia, Poland, Romania, Czech Republic, Ukraine, Slovakia, Bulgaria)  ·  Asia-Pacific (China, Japan, South Korea, India, Australia, New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Taiwan, Bangladesh)  ·  South and Central America (Brazil, Argentina, Chile, Colombia, Peru)  ·  Middle East and Africa (Saudi Arabia, United Arab Emirates, Kuwait, Bahrain, Qatar, Oman, Turkiye, South Africa, Egypt, Nigeria, Algeria)
Deliverables Historical analysis with CAGR · PEST & SWOT analysis · Market Size at Global, Regional, and Country Levels · Competitive heat map · Company profiles · Excel dataset
Report Code BMIPUB00036496
Lead Analyst Krishna Sunthwal — Analyst, Research · View Profile
With Full Report Access

Gain actionable insights with 350 pages of in-depth Pharmacogenomics Market, including historical trends, 8-year market forecasts, SWOT analysis, competitive landscapes, and downloadable Excel datasets in a single comprehensive package.